GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of unpopular opinion: most of what gets said here about 15mg is guesswork — 19 comments in the full submission. View in context.
333
c/tirzepatide·submitted 3 months ago by u/mikkel_ogunleye

unpopular opinion: most of what gets said here about 15mg is guesswork

Titrationbranch of 7 comments

unpopular opinion: most of what gets said here about 15mg is guesswork, and I am aware this is a minority view on this board. 15mg. Those are measured, not estimated, and not rounded up in my favour. 32kg over 66 weeks, never went past 10mg, and injection-site soreness stayed mild the whole way. Posting because the…

Read the full submission and all 19 comments →

This branch

7 comments, started 3 months ago
u/ahmed_iyer36 points·3 months ago

SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.

replysharereportpermalink
u/discount_math_dm10 points·3 months ago

Yes. I stepped to 12.5 because the calendar said so, not because anything needed fixing, and I regretted it for a fortnight.

replysharereportpermalink
u/mikkel_ogunleyeOP4 points·3 months ago

Appetite effect for me is flat across seven days. On sema it was a wave. Same person, different molecule.

replysharereportpermalink
u/elin_ferrari8 points·3 months ago

The 21% figure is a 72-week mean on the highest arm. Quoting it as what someone should expect by week 33 is not a fair reading.

replysharereportpermalink
u/bastian_ekstrom5 points·3 months ago·edited

Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.

replysharereportpermalink
u/mikkel_ogunleyeOP26 points·3 months ago

stepping every four weeks is a ceiling on speed, not a schedule you must hit

replysharereportpermalink
u/nordic_pricing17 points·3 months ago

I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your reflux pattern is a guess.

replysharereportpermalink

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.